Results 1 to 10 of about 54,777 (206)
Human Papillomavirus Vaccines. [PDF]
J Infect Dis, 2021 Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Markowitz LE, Schiller JT.
europepmc +4 more sources
Human Papillomavirus Vaccines: An Updated Review [PDF]
Vaccines, 2020 Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated
Liqin Cheng, Yan Wang, Juan Du
doaj +2 more sources
Reviews in Medical Virology, 2006 AbstractA wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intra‐epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention of infection by prophylactic vaccination would be an ...
Mia R, Schmiedeskamp, Denise R, Kockler
europepmc +6 more sources
Human papillomavirus vaccines. [PDF]
CMAJ, 2017 Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Ismail SJ, Deeks SL.
europepmc +4 more sources
A Pocket Manual for Human Papillomavirus Vaccines [PDF]
VaccinesHuman papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for the majority of cervical, anal, and vaginal cancers. The first prophylactic HPV vaccine was introduced in the United States in 2006.
Natalie A. Voss +2 more
doaj +2 more sources
Human papillomavirus vaccines: A great leap forward [PDF]
Case Reports in Women's Health, 2022 Marie Louise Frevert +1 more
doaj +2 more sources
Frontiers in Bioscience, 1998 The considerable morbidity and mortality associated with certain human papillomaviruses (HPV) has provided the impetus for HPV vaccine development. The design of such vaccines has evolved from an understanding of the nature of HPV infections and their consequences, together with evaluation of the efficacy of different approaches to vaccination in ...
Duggan-Keen, M +3 more
+7 more sources
Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan
Women's Health, 2023 Background: Although recommended for all member states of World Health Organization, there is no national human papillomavirus vaccination program in Kazakhstan.
Aisha Babi +11 more
doaj +1 more source
Prices of paediatric vaccines in European vaccination programmes
Vaccine: X, 2023 Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe.
Heini Salo +6 more
doaj +1 more source
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: Restoration of previously unpublished methodology [PDF]
, 2020 Purpose: Trustworthy reporting of quadrivalent human papillomavirus (HPV) vaccine trials is the foundation for assessing the vaccine's risks and benefits.
Bourgeois, Florence +7 more
core +1 more source